⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 1, 2024HeliyonOpen Access

Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer

D. Dai Hongkai Zhuang Mao Shu Lezi Chen Long Chen Hongmei Wu Bo Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

The impact of N7-methylguanosine (m7G) on tumor progression and the regulatory role of microRNAs (miRNAs) in immune function significantly influence breast cancer (BC) prognosis. Investigating the interplay between m7G modification and miRNAs provides novel insights for assessing prognostics and drug responses in BC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dai et al. (2024) studied this question.

synapsesocial.com/papers/68e7115bb6db64358768a3d1 https://doi.org/10.1016/j.heliyon.2024.e29326

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1N7-methylguanosine (m7G) modification in breast cancer: clinical significances and molecular mechanisms2025 · 6 citations
2Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancersOriginal Research · 2022 · 11 citations
3N7-Methylguanosine Modification in Colorectal Cancer: Molecular Insights and Clinical ImplicationsReview · 2026
4An N7-methylguanosine-Related gene signature predicts prognosis and immune landscape in triple-negative breast cancerOriginal Research · 2026
5Pan‐Cancer Analysis Links Altered <scp>RNA m<sup>7</sup>G</scp> Methyltransferase Expression to Oncogenic Pathways, Immune Cell Infiltrations and Overall Survival2024 · 1 citations